Financhill
Sell
34

ICUI Quote, Financials, Valuation and Earnings

Last price:
$147.06
Seasonality move :
3.33%
Day range:
$142.83 - $150.74
52-week range:
$93.36 - $196.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.51x
P/B ratio:
1.83x
Volume:
563.3K
Avg. volume:
268.2K
1-year change:
49.28%
Market cap:
$3.6B
Revenue:
$2.4B
EPS (TTM):
-$4.83

Earnings Data

Next earnings date for ICUI
May 07
2025
Most recent earnings per share
-$0.97
Missed by $2.45
(Feb 27/2025)
Consensus Estimate
$1.48
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ICUI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $574.2M -- -- $1.28 --
02/27/2025 Q4 $599.1M $629.8M -$0.97 $1.48 -$2.45
11/12/2024 Q3 $576.7M $589.1M -$1.35 $1.25 -$2.60
08/07/2024 Q2 $553.7M $596.5M -$0.88 $1.00 -$1.88
05/07/2024 Q1 $554M $566.7M -$1.63 $0.82 -$2.45
02/27/2024 Q4 $568.3M $587.9M -$0.71 $1.19 -$1.90
11/06/2023 Q3 $570.8M $553.3M $0.30 $1.39 -$1.09
08/07/2023 Q2 $562.9M $549.3M -$0.41 $1.60 -$2.01
05/08/2023 Q1 $565.3M $568.6M -$0.41 $1.43 -$1.84
02/27/2023 Q4 -- $578M -$0.65 -- --
11/07/2022 Q3 -- $597.9M -$0.55 -- --
08/08/2022 Q2 -- $561M -$0.31 -- --
05/09/2022 Q1 -- $543.1M -$1.61 -- --
02/24/2022 Q4 -- $340.5M $0.91 -- --
11/03/2021 Q3 -- $336.1M $1.43 -- --
08/04/2021 Q2 -- $321.7M $1.31 -- --
05/06/2021 Q1 -- $318M $1.09 -- --
02/25/2021 Q4 -- $320.5M $1.21 -- --
11/05/2020 Q3 -- $318.6M $1.16 -- --
08/10/2020 Q2 -- $303.4M $0.88 -- --
05/07/2020 Q1 -- $328.6M $0.78 -- --
02/27/2020 Q4 -- $315.5M $0.96 -- --
11/11/2019 Q3 -- $307.5M $1.24 -- --
08/07/2019 Q2 -- $312.3M $1.06 -- --
05/09/2019 Q1 -- $330.9M $1.44 -- --
02/28/2019 Q4 -- $340.4M -$0.36 -- --
11/08/2018 Q3 -- $327.2M $0.01 -- --
08/09/2018 Q2 -- $360.5M $1.44 -- --
05/09/2018 Q1 -- $372M $0.23 -- --
03/01/2018 Q4 -- $370.1M $2.33 -- --
11/09/2017 Q3 -- $343.2M $0.01 -- --
08/09/2017 Q2 -- $331.5M -$1.87 -- --
05/10/2017 Q1 -- $247.7M $2.86 -- --
03/01/2017 Q4 -- $95.7M $0.54 -- --
11/09/2016 Q3 -- $97.1M $1.09 -- --
08/08/2016 Q2 -- $96.7M $0.98 -- --
05/10/2016 Q1 -- $89.9M $1.08 -- --
02/03/2016 Q4 -- $90.4M $0.33 -- --
11/05/2015 Q3 -- $86M $0.98 -- --
08/10/2015 Q2 -- $83.8M $0.83 -- --
05/05/2015 Q1 -- $81.5M $0.60 -- --

ICU Medical Earnings Questions

  • How Much did ICU Medical Generate in Revenue Last Quarter?

    ICU Medical reported $629.8M worth of top line sales in its most recent quarter.

  • Did ICU Medical Beat Earnings Last Quarter?

    ICU Medical announced earnings per share of -$0.97 which represents a miss of analyst forecast a $1.48 per share.

  • Is ICU Medical Profitable?

    ICU Medical reported $227.3M that represents $9.28 per share over the last quarter.

  • What is the Analyst Consensus for ICU Medical EPS Next Year?

    ICU Medical's earnings are forecast to grow from -$4.83 per share to $6.77 per share next year representing an increase of --.

  • When is ICU Medical's Earnings Date?

    ICU Medical's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock